Lite Strategy (LITS) EBITDA Margin (QoQ) (2016 - 2023)
Lite Strategy (LITS) EBITDA Margin (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - |
| 10 | Lite Strategy | 36.25 Mn | 28.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 84,513.00 |
| Jun 30, 2023 | -48,237.00 |
| Mar 31, 2023 | -30,536.00 |
| Dec 31, 2022 | 23,596.00 |
| Sep 30, 2022 | -6,680.00 |
| Jun 30, 2022 | 8,049.00 |
| Mar 31, 2022 | -7,342.00 |
| Dec 31, 2021 | 11,022.00 |
| Sep 30, 2021 | -5,159.00 |
| Jun 30, 2021 | -541.00 |
| Mar 31, 2021 | -7,695.00 |
| Dec 31, 2020 | 6,733.00 |
| Sep 30, 2020 | -23,756.00 |
| Jun 30, 2020 | 104,525.00 |
| Mar 31, 2020 | 20,105.00 |
| Dec 31, 2019 | -11,028.00 |
| Sep 30, 2019 | -5,044.00 |
| Jun 30, 2019 | -3,048.00 |
| Mar 31, 2019 | -43,185.00 |
| Dec 31, 2018 | 147,771.00 |